Younger patients autologous stem cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy22

Stem Cells Hematopoietic Stem Cells Autografts Embryonic Stem Cells Adult Stem Cells Mesenchymal Stromal Cells Pluripotent Stem Cells Bone Marrow Neural Stem Cells T-Lymphocytes Bone Marrow Cells Induced Pluripotent Stem Cells Cells, Cultured Multipotent Stem Cells Antilymphocyte Serum Fetal Stem Cells Fetal Blood Spermatogonia Neoplastic Stem Cells Plant Stems Allografts Blood Cells

Organisms4

Transplantation Chimera Mice, Inbred C57BL Cytomegalovirus Mice, SCID

Diseases56

Multiple Myeloma Hodgkin Disease Lymphoma, Non-Hodgkin Recurrence Graft vs Host Disease Hematologic Neoplasms Lymphoma, Mantle-Cell Amyloidosis Lymphoma, Follicular Lymphoma, T-Cell, Peripheral Lymphoma Lymphoma, Large B-Cell, Diffuse Neoplasm, Residual Leukemia, Myeloid, Acute Enteropathy-Associated T-Cell Lymphoma Myelodysplastic Syndromes Lymphoma, B-Cell Leukemia, Plasma Cell Neoplasms, Second Primary Leukemia, Myeloid Leukemia Neoplasm Recurrence, Local Acute Disease Neutropenia Hepatic Veno-Occlusive Disease Disease Progression Precursor Cell Lymphoblastic Leukemia-Lymphoma Lymphoma, AIDS-Related Neuroblastoma Hematologic Diseases Neoplasms Stomatitis Leukemia, Myelogenous, Chronic, BCR-ABL Positive Cytomegalovirus Infections Anemia, Aplastic Breast Neoplasms Mucositis Infection Severe Combined Immunodeficiency Medulloblastoma Lymphoproliferative Disorders Chromosome Aberrations Opportunistic Infections Leukemia, Lymphocytic, Chronic, B-Cell Central Nervous System Neoplasms Postoperative Complications Thrombocytopenia Disease Models, Animal Blood Group Incompatibility Paraproteinemias Chronic Disease Mycoses Roseolovirus Infections Bronchiolitis Obliterans Epstein-Barr Virus Infections Liver Failure

Chemicals and Drugs50

Melphalan Myeloablative Agonists Etoposide Cytarabine Cyclophosphamide Carmustine Vincristine Thiotepa Busulfan Boronic Acids Dexamethasone Pyrazines Antibodies, Monoclonal, Murine-Derived Antigens, CD34 Doxorubicin Thalidomide Antineoplastic Agents, Alkylating Prednisone Ifosfamide Podophyllotoxin Granulocyte Colony-Stimulating Factor Antineoplastic Agents Idarubicin Mitoxantrone Immunosuppressive Agents Keratins, Type II Antibodies, Monoclonal Carboplatin Immunoglobulin Light Chains Vidarabine HLA Antigens Cisplatin Antilymphocyte Serum Immunoconjugates Stem Cell Factor Bleomycin Cyclosporine Recombinant Proteins Minor Histocompatibility Antigens Methotrexate Antigens, CD Tacrolimus Antigens, CD20 Prednisolone Immunologic Factors Nitrogen Mustard Compounds Biological Markers Myeloma Proteins Antibodies, Neoplasm Ganciclovir

Analytical, Diagnostic and Therapeutic Techniques and Equipment91

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Transplantation, Homologous Transplantation Conditioning Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Remission Induction Treatment Outcome Salvage Therapy Disease-Free Survival Hematopoietic Stem Cell Mobilization Bone Marrow Transplantation Bone Marrow Purging Survival Rate Whole-Body Irradiation Retrospective Studies Survival Analysis Prognosis Liver Transplantation Follow-Up Studies Mesenchymal Stem Cell Transplantation Leukapheresis Induction Chemotherapy Maintenance Chemotherapy Cord Blood Stem Cell Transplantation Cell Transplantation Kidney Transplantation Infusions, Spinal Blood Component Removal Histocompatibility Testing Prospective Studies Feasibility Studies Fatal Outcome Life Tables Radioimmunotherapy Heart Transplantation Risk Factors Lung Transplantation Immunotherapy Drug Administration Schedule Blood Transfusion, Autologous Organ Transplantation Transplantation, Isogeneic Lymphocyte Transfusion Clinical Trials as Topic Kaplan-Meier Estimate Flow Cytometry Transplantation Islets of Langerhans Transplantation Immunosuppression Treatment Failure Pilot Projects Lymphocyte Depletion Neoplasm Staging Positron-Emission Tomography Cell Separation Pancreas Transplantation Immunophenotyping Platelet Count Predictive Value of Tests Donor Selection Cell Culture Techniques Transplantation, Heterologous Immunomagnetic Separation Severity of Illness Index Randomized Controlled Trials as Topic Stem Cell Research Cell- and Tissue-Based Therapy Fetal Tissue Transplantation Leukocyte Count Multivariate Analysis Proportional Hazards Models Transplantation, Heterotopic Disease Models, Animal Cohort Studies Colony-Forming Units Assay Platelet Transfusion Heart-Lung Transplantation Immunotherapy, Adoptive Radiotherapy Lymphocyte Count Incidence Polymerase Chain Reaction Drug Therapy Blood Cell Count Cell Count Reverse Transcriptase Polymerase Chain Reaction Coculture Techniques Leukocyte Transfusion

Psychiatry and Psychology1

Phenomena and Processes26

Graft Survival Time Factors Cell Differentiation Histocompatibility Hematopoiesis Graft vs Leukemia Effect Transplantation Immunology Stem Cell Niche Graft Rejection Graft vs Tumor Effect Chimerism Dose-Response Relationship, Drug Cell Lineage Platelet Count Cell Proliferation Regeneration Transplantation Tolerance Immunocompromised Host Chromosome Aberrations Virus Activation Leukocyte Count Cell Survival Lymphocyte Count Blood Cell Count Cell Count Phenotype

Disciplines and Occupations2

Stem Cell Research Regenerative Medicine

Anthropology, Education, Sociology and Social Phenomena2

Siblings Quality of Life

Humanities1

Quality of Life

Information Science4

Survival Rate Fatal Outcome Life Tables Incidence

Named Groups5

Tissue Donors Siblings Unrelated Donors Living Donors Blood Donors

Health Care25

Treatment Outcome Disease-Free Survival Survival Rate Retrospective Studies Survival Analysis Follow-Up Studies Prospective Studies Feasibility Studies Fatal Outcome Life Tables Risk Factors Clinical Trials as Topic Kaplan-Meier Estimate Treatment Failure Pilot Projects Predictive Value of Tests Age Factors Donor Selection Severity of Illness Index Randomized Controlled Trials as Topic Multivariate Analysis Proportional Hazards Models Cohort Studies Tissue and Organ Procurement Incidence

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Multiple Myeloma Melphalan Transplantation, Homologous Transplantation Conditioning Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Remission Induction Treatment Outcome Stem Cells Salvage Therapy Disease-Free Survival Hodgkin Disease Myeloablative Agonists Etoposide Lymphoma, Non-Hodgkin Recurrence Cytarabine Cyclophosphamide Carmustine Graft vs Host Disease Hematopoietic Stem Cell Mobilization Bone Marrow Transplantation Vincristine Bone Marrow Purging Survival Rate Thiotepa Hematologic Neoplasms Lymphoma, Mantle-Cell Whole-Body Irradiation Amyloidosis Retrospective Studies Survival Analysis Hematopoietic Stem Cells Busulfan Boronic Acids Dexamethasone Pyrazines Graft Survival Antibodies, Monoclonal, Murine-Derived Lymphoma, Follicular Autografts Antigens, CD34 Prognosis Lymphoma, T-Cell, Peripheral Liver Transplantation Doxorubicin Thalidomide Follow-Up Studies Antineoplastic Agents, Alkylating Mesenchymal Stem Cell Transplantation Prednisone Leukapheresis Ifosfamide Podophyllotoxin Granulocyte Colony-Stimulating Factor Time Factors Lymphoma Transplantation Chimera Induction Chemotherapy Lymphoma, Large B-Cell, Diffuse Neoplasm, Residual Tissue Donors Maintenance Chemotherapy Cord Blood Stem Cell Transplantation Cell Transplantation Leukemia, Myeloid, Acute Kidney Transplantation Enteropathy-Associated T-Cell Lymphoma Embryonic Stem Cells Antineoplastic Agents Myelodysplastic Syndromes Lymphoma, B-Cell Infusions, Spinal Leukemia, Plasma Cell Idarubicin Adult Stem Cells Mitoxantrone Neoplasms, Second Primary Blood Component Removal Immunosuppressive Agents Histocompatibility Testing Prospective Studies Keratins, Type II Cell Differentiation Histocompatibility Feasibility Studies Antibodies, Monoclonal Mesenchymal Stromal Cells Leukemia, Myeloid Fatal Outcome Life Tables Carboplatin Radioimmunotherapy Hematopoiesis Graft vs Leukemia Effect Immunoglobulin Light Chains

No FAQ available that match "younger patients autologous stem cell transplantation"